SCHEMBL7951291

SCHEMBL7951291

CCCOc1ccc(Cl)cc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPT P10636 2/20 0.50
LMNA P02545 2/20 0.50
NR1I2 O75469 1/20 0.50
CHRM2 P08172 1/20 0.50
CYP3A4 P08684 1/20 0.50
ADRA2A P08913 1/20 0.50
OPRK1 P41145 1/20 0.50
SLC6A3 Q01959 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HSD17B10 Q99714 1/20 0.49
GAA P10253 3/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
GLA P06280 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
HTR2C P28335 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13884693 0.92 MEN1 (0.56) HTR2BMEN1KMT2AMAPTLMNA
SCHEMBL8337247 0.90 MEN1 (0.65) HTR2BMEN1KMT2AMAPTLMNA
SCHEMBL11627993 0.87 MEN1 (0.53) MEN1KMT2AMAPTLMNAHDAC6
SCHEMBL12505380 0.86 LMNA (0.48) HTR2BMEN1KMT2AMAPTLMNA
SCHEMBL20522075 0.86 GAA (0.61) MAPTLMNAGAAALDH1A1TSHR
SCHEMBL12505492 0.86 NPC1 (0.47) MEN1KMT2AMAPTGAAALDH1A1
SCHEMBL14610582 0.85 PTPN11 (0.50) HTR2BMEN1KMT2AMAPTLMNA
SCHEMBL12505368 0.85 MAPT (0.49) HTR2BMEN1KMT2AMAPTLMNA
SCHEMBL7962802 0.84 HTR2C (0.46) HTR2BMEN1KMT2AMAPTLMNA
SCHEMBL12505488 0.84 TP53 (0.49) HTR2BMEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0352960-B1 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE FRENCH LAB (GB) 1994-10-26 EP disclosed
US-5073559-A 2-Substituted purinone having phosphodiesterase inhibitory activity SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-17 US disclosed
EP-0352960-A2 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-31 EP disclosed